Acurx Pharmaceuticals, Inc.
ACXP
$4.08
$0.225.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.58% | 25.28% | -35.68% | -9.41% | -28.70% |
| Total Receivables | -- | -- | -47.54% | 90.61% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -66.89% | 61.44% | -18.49% | -27.08% | -10.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 28.14% | 24.56% | -35.52% | -9.08% | -27.76% |
|
|
|||||
| Total Current Assets | 28.14% | 24.56% | -35.52% | -9.08% | -27.76% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 28.14% | 24.56% | -35.52% | -9.08% | -27.76% |
|
|
|||||
| Total Accounts Payable | 29.41% | -29.17% | -74.87% | 89.11% | 9.78% |
| Total Accrued Expenses | 3.87% | -23.08% | -1.87% | 4.99% | 1.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.91% | -23.09% | -2.29% | 5.26% | 1.37% |
|
|
|||||
| Total Current Liabilities | 3.91% | -23.09% | -2.29% | 5.26% | 1.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.91% | -23.09% | -2.29% | 5.26% | 1.37% |
|
|
|||||
| Common Stock & APIC | 4.88% | 5.66% | 1.09% | 3.16% | 2.44% |
| Retained Earnings | -3.23% | -3.19% | -4.31% | -4.57% | -7.16% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 54.29% | 275.78% | -76.91% | -22.28% | -42.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 54.29% | 275.78% | -76.91% | -22.28% | -42.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 54.29% | 275.78% | -76.91% | -22.28% | -42.86% |
|
|
|||||